Digital Health Landscape 2015: Top 100 Influencers & Brands
Onalytica B2B
MARCH 18, 2015
The FDA (Food and Drug Administration) recently approved the marketing of consumer genetic testing company 23andMe’s test for Bloom Syndrome , which allows for risk-based family planning. HealthKit is already the market leader among hospitals looking to move data from patients’ at-home devices to their electronic health records.
Let's personalize your content